Study shows genetically modified pluripotent stem cells may evade immunological rejection after transplantation

Researchers from University of Arizona Health Sciences are one step closer to solving one of the biggest barriers to regenerative medicine: immunological rejection by the recipient.

Related Keywords

Tucson ,Arizona ,United States ,New York ,University Of Arizona ,Boston ,Massachusetts ,Paula Alonso Guallart ,Frederickj Monsma Jr ,Todda Fehniger ,Johnp Atkinson ,Deepta Bhattacharya ,Shondram Pruett Miller ,Hannah Pizzato ,James Woods ,Jonp Connelly ,University Of Arizona Health Sciences Center ,York Stem Cell Foundation Research Institute ,Washington University School Of Medicine ,Uarizona Cancer Center ,Tucson Department Of Immunobiology ,Uarizona Health Sciences ,Uarizona Health Sciences Center ,Department Of Immunobiology Deepta Bhattacharya ,Diabetes Research Foundation ,University Of Arizona Health Sciences ,College Of Medicine ,Uarizona College Of Medicine ,Jude Children Research Hospital ,York Stem Cell Foundation ,Arizona Health ,Advanced Molecular ,Immunological Therapies ,Arizona Health Sciences ,Human Pluripotent Stem Cell Lines ,Evade Xenogeneic Transplantation ,Stem Cell Reports ,Jude Children ,Research Hospital ,Washington University School ,Cancer Center ,Health Sciences Center ,New York Stem Cell Foundation ,Juvenile Diabetes Research Foundation ,Clade Therapeutics ,Tech Launch Arizona ,